WithdrawnNCT04223661
Frailty Score-guided Dosing of Lenalidomide, Dexamethasone and Daratumumab Induction Therapy
PHASE2 · 0 planned enrolment
- Countries listed
- 1
- Registry update
- December 8, 2022
Registry Intervention View
dexamethasone
Trial registrations containing the exact intervention label dexamethasone.
Exact registry label · Not reported
6 linked registrations
No aliases or equivalent products have been inferred.
Topics connected by trial metadata
3 linked registrations report posted results
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →Registered trials
CompletedNCT01849783
Autologous Stem Cell Transplant Followed By Maintenance Therapy in Treating Elderly Patients With Multiple Myeloma
PHASE2 · 41 planned enrolment
- Countries listed
- 1
- Registry update
- May 11, 2022
CompletedNCT00511706
Safety and Efficacy of a New Treatment as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) Treatment in Patients With Age-Related Macular Degeneration (AMD)
PHASE2 · 243 planned enrolment
- Countries listed
- 9
- Registry update
- April 25, 2019
WithdrawnNCT00457678
Second Line Therapy to Treat Age-related Macular Degeneration (AMD) for Patients Not Responding Well to Lucentis Therapy by Itself
PHASE2 · 0 planned enrolment
- Countries listed
- 0
- Registry update
- August 23, 2017
CompletedNCT00805649
Combined Therapy in Age-Related Macular Degeneration (ARMD)
PHASE4 · 150 planned enrolment
- Countries listed
- 1
- Registry update
- September 27, 2012
CompletedNCT00775411
Safety and Efficacy of a New Therapy as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) in Subjects With Wet Age-Related Macular Degeneration (AMD)
PHASE2 · 44 planned enrolment
- Countries listed
- 3
- Registry update
- September 3, 2012